Tony Chen, Chief Executive Officer
Tony is responsible for setting PrimeVax’s strategy direction. Tony works closely with the PrimeVax Scientific Board of Advisors to ensure that all strategies are supported by robust science.
Tony’s experience spans management and strategy consulting, clinical research services, and the US Department of Health and Human Services (HHS). Prior to leading PrimeVax, Tony built and managed various strategy and management consulting teams in the healthcare space. Specific subject areas included launch planning, pricing and market access, commercial contracting, and government compliance. Prior to this role, Tony helped implement the Affordable Care Act at HHS.
Tony has extensive knowledge of the US healthcare system, the current drivers of change, and their implications on PrimeVax’s development and launch strategy.
Relevant qualifications: Consulting practice development, oncology marketplace, clinical / commercial development roadmapping, and direct US government healthcare reform experience.
Previous organizational experience: Government regulation implementation, pharma manufacturer maturity planning, organizational transformations, and business process reengineering.
Previous industry experience includes immunotherapy launch strategy, autoimmune disorders, and orphan diseases.
Chief Executive Officer